Ischemic Cerebral Stroke Market Outlook and Forecast up to 2024
Ischemic cerebral stroke occurs when blood vessels that supply blood to brain are blocked due to the formation of blood clots resulting in the corresponding loss of neurologic function. The symptoms of ischemic cerebral stroke complains include the abrupt onset of hemiparesis, quadriparesis and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia and decrease in the level of consciousness.
Ischemic Cerebral Stroke Market: Segmentation
Ischemic cerebral stroke market can be segmented on the basis of the diagnostic techniques and treatments available. On the basis of the diagnostic techniques, ischemic cerebral stroke market is classifies into following segments:
Computed tomography (CT) angiography and CT scan
Carotid duplex scanning
Magnetic resonance imaging (MRI)
Digital subtraction angiography
Obtain Report Details: http://www.transparencymarketresearch.com/ischemic-cerebral-stroke-market.html
CT scan is the most common technique, which is used for diagnosis of ischemic cerebral stroke, majorly due to its efficiency to capture the images in the form of axial slices or as volume studies in three-dimensional form. These three-dimensional images provide the doctor, better insight about the stroke condition. In addition to imaging diagnosis, doctors also perform lumbar puncture and other laboratory testing such as complete blood count, basic chemistry panel, coagulation studies and toxicology screening. These tests are performed to discover any additional disease condition which could hinder the treatment such as meningitis, coagulopathy and other concurrent illness such as diabetes, hypoglycemia, renal insufficiency and hyponatremia.
On the basis of the treatment, the ischemic cerebral stroke market is majorly classified into two classes namely medication treatment and surgical treatment. Surgical treatment involves the removal of the blood clots and fatty deposits from the artery in the neck. The surgery helps in reducing the risk of another stroke, but this method of treatment is not suitable for everyone. Therefore, medications capture the major share of the ischemic cerebral stroke treatment market. Drugs that are usually prescribed for treatment include:
Aspirin and Clopidrogel
Alteplase captures the major share of the ischemic cerebral stroke medication market followed by warfarin. Alteplase is used to break up blood clots and for restoring blood flow in the brain while warfarin prevents formation of blood clot. Aspirin and clopidrogel are prescribed to reduce the rate of formation of blood clots after a stroke. Moreover, many market players in ischemic cerebral stroke market are performing research for developing drugs that take less time for breaking blood clots and restoring blood flow. For instance, Stempeutics Research Pvt., Ltd. has developed a drug with the namely Stempeucel which is expected to show efficient results in the forecast period leading to the growth of ischemic cerebral stroke market. Currently, Stempeucel is under phase II clinical trials for treatment of ischemic cerebral stroke.
Ischemic Cerebral Stroke Market: region-wise Insight
North America leads the ischemic cerebral stroke market followed by Europe majorly due to high prevalence of ischemic cerebral stroke. According to the Centers for Disease Control and Prevention (CDC), stroke is a leading cause of death in U.S. and kills around 130,000 people every year and around 85% of the strokes are ischemic cerebral stroke. Such high prevalence of the disease leads to the increased need for diagnosis and treatment medications resulting in the growth of ischemic cerebral stroke market.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13256
Asia-Pacific is growing rapidly in the ischemic cerebral stroke treatments market due to increasing prevalence of the disease and growing government support for spreading awareness about ischemic cerebral stroke. As for instance, in 2008, the Regional Comprehensive Stroke Center (CSC) program in South Korea was initiated by the Ministry of Health and Welfare of South Korea to spread awareness about the availability of treatments and to decrease the mortality rate of the stroke nationwide.
Ischemic Cerebral Stroke Market: Key Players
Other major players in the ischemic cerebral stroke market include Bayer AG, Boehringer Ingelheim GmbH, H. Lundbeck A/S, Bristol-Myers Squibb Company, ThromboGenics NV, Vernalis plc and Neurotec Pharma SL.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ischemic Cerebral Stroke Market Outlook and Forecast up to 2024 here
News-ID: 634010 • Views: 187
More Releases from TMR - Research Reports
Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to
More Releases for Ischemic
Transient Ischemic Attack Market Forecast by 2025
Recent Transient Ischemic Attack market research and the current scenario as well as future market potential of "Global Transient Ischemic Attack Market Professional Survey Report 2020". The Transient Ischemic Attack Market comprehensively describes the market and prognosticates it to describe a highly illustrious growth during the anticipated years. The report offers an in-depth analysis of current and future Transient Ischemic Attack Market outlook across the globe. The report is projected
Research report prospects the Ischemic Heart Disease Treatment Market
Ischemic heart disease blocks blood supply to the heart. It is also known as coronary artery disease. Blood vessels get blocked or narrowed due to cholesterol deposition on the walls. This decreases nutrients and oxygen supply to heart muscles, which is important for appropriate functioning of the heart. This results in a part of the heart being rapidly run down of its blood supply and causes death of heart tissues.
Global Ischemic Heart Disease Drugs Market Research Report 2017
Global Ischemic Heart Disease Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including AstraZeneca Bayer Actelion Bristol-Myers Squibb Boehringer Ingelheim ... On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Anti-dyslipidemic Drugs Calcium Channel Blockers Antithrombotic Agents ACE Inhibitors Vasodilators Beta-blockers On the basis on the end users/applications, this report focuses on the status and outlook for major
Ischemic Stroke - Pipeline Insight and Therapeutic Assessment 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Ischemic Stroke - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Ischemic Stroke. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265452 A comparative pipeline therapeutics assessment of Ischemic Stroke by development stage,
North America Leads the Ischemic Cerebral Stroke Market Followed by Europe Major …
Ischemic Cerebral Stroke Market: Overview Ischemic cerebral stroke occurs when blood vessels that supply blood to brain are blocked due to the formation of blood clots resulting in the corresponding loss of neurologic function. The symptoms of ischemic cerebral stroke complains include the abrupt onset of hemiparesis, quadriparesis and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia and decrease in the level
Acute Ischemic Stroke Diagnosis Market Size, Share and Growth 2021
According to the report “Acute Ischemic Stroke Diagnosis and Treatment Market “published by Market Data Forecast, the global market is projected to reach USD 2508 million by 2021, at a CAGR of 6.7% from 2016 to 2021. View Report at http://www.marketdataforecast.com/market-reports/global-acute-ischemic-stroke-diagnosis-market-265/ Acute Ischemic stroke can be defined as loss of function in certain parts of brain due to lack of blood supply to the brain. Rising prevalence of acute ischemia stroke cases